Our top pick for
Building a portfolio
Passage Bio, Inc is a biotechnology business based in the US. Passage Bio shares (PASG) are listed on the NASDAQ and all prices are listed in US Dollars. Passage Bio employs 20 staff and has a market cap (total outstanding shares value) of USD$1.3 billion.
|Latest market close||USD$27.72|
|52-week range||USD$8.09 - USD$38.23|
|50-day moving average||USD$18.3926|
|200-day moving average||USD$19.2579|
|Wall St. target price||USD$28.5|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||N/A|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-11)||N/A|
|1 month (2020-12-22)||4.80%|
|3 months (2020-10-18)||N/A|
|6 months (2020-07-18)||N/A|
|1 year (2020-01-18)||N/A|
|2 years (2019-01-18)||N/A|
|3 years (2018-01-18)||N/A|
|5 years (2016-01-18)||N/A|
|Gross profit TTM||USD$0|
|Return on assets TTM||-19.96%|
|Return on equity TTM||-32.9%|
|Market capitalisation||USD$1.3 billion|
TTM: trailing 12 months
There are currently 1.4 million Passage Bio shares held short by investors – that's known as Passage Bio's "short interest". This figure is 5.7% up from 1.3 million last month.
There are a few different ways that this level of interest in shorting Passage Bio shares can be evaluated.
Passage Bio's "short interest ratio" (SIR) is the quantity of Passage Bio shares currently shorted divided by the average quantity of Passage Bio shares traded daily (recently around 160583.29519451). Passage Bio's SIR currently stands at 8.74. In other words for every 100,000 Passage Bio shares traded daily on the market, roughly 8740 shares are currently held short.
However Passage Bio's short interest can also be evaluated against the total number of Passage Bio shares, or, against the total number of tradable Passage Bio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Passage Bio's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Passage Bio shares in existence, roughly 30 shares are currently held short) or 0.0507% of the tradable shares (for every 100,000 tradable Passage Bio shares, roughly 51 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Passage Bio.
Find out more about how you can short Passage Bio stock.
We're not expecting Passage Bio to pay a dividend over the next 12 months.
Passage Bio, Inc., a genetic medicines company, focuses on developing transformative therapies for rare monogenic central nervous system (CNS) diseases. It has research, collaboration, and license agreement with the University of Pennsylvania and its gene therapy program; and The Trustees of the University of Pennsylvania for research and development collaborations, and exclusive license rights to patents for certain products and technologies. The company was founded in 2017 and is based in Philadelphia, Pennsylvania.
Steps to owning and managing SSNC, with 24-hour and historical pricing before you buy.
Steps to owning and managing SMBC, with 24-hour and historical pricing before you buy.
Steps to owning and managing SMED, with 24-hour and historical pricing before you buy.
Steps to owning and managing SJW, with 24-hour and historical pricing before you buy.
Steps to owning and managing SFBS, with 24-hour and historical pricing before you buy.
Steps to owning and managing LEDS, with 24-hour and historical pricing before you buy.
Steps to owning and managing SC, with 24-hour and historical pricing before you buy.
Steps to owning and managing RTW, with 24-hour and historical pricing before you buy.
Steps to owning and managing RIVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing RVSB, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.